EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early mortality in STXBP1-related disorders

Francesca Furia, Charlene Son Rigby, Ingrid E Scheffer, Nicholas Allen, Kate Baker, Christian Hengsbach, Josua Kegele, James Goss, Kathleen Gorman, Misra-Isrie Mala, Francesco Nicita, Talia Allan und 7 weitere

Neurological Sciences · 2025

DOI: 10.1007/s10072-024-07783-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurological Sciences, 2025. Verfasst von Francesca Furia und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epilepsy Genetics and Personalized Treatment, Danish Epilepsy Center, Member of the European Reference Network EpiCARE, University of S…. Hauptthemen laut MEDLINE: Munc18 Proteins, Sudden Unexpected Death in Epilepsy, Drug Resistant Epilepsy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: STXBP1 Foundation, University of Southern Denmark.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pathogenic variants in STXBP1 cause a spectrum of disorders mainly consisting of developmental and epileptic encephalopathy (DEE), often featuring drug-resistant epilepsy. An increased mortality risk occurs in individuals with drug-resistant epilepsy and DEE, with sudden unexpected death in epilepsy (SUDEP) often the major cause of death. This study aimed to identify the rate and causes of mortality in STXBP1 -related disorders.

Methods

Through an international call, we analyzed data on individuals with STXBP1 pathogenic variants, who passed away from causes related to their disease.

Results

We estimated a mortality rate of 3.2% (31/966), based on the STXBP1 Foundation and the STXBP1 Global Connect registry. In total, we analyzed data on 40 individuals (23 males) harboring pathogenic STXBP1 variants, collected from different centers worldwide. They died at a median age of 13 years (range: 11 months—46 years). The most common cause of death was SUDEP (36%), followed by pulmonary infections and respiratory complications (33%). The incidence of SUDEP peaked in mid-childhood, while non-SUDEP causes were more frequent in early childhood or adulthood (p = 0.006). In the most severe phenotypes, death was related to non-SUDEP causes ( p = 0.018).

Conclusion

We found a mortality rate in STXBP1 -related disorders similar to other DEEs, with an early age at death and SUDEP as well as pulmonary infections as the main cause of death. These findings assist in prognostic evaluation and genetic counseling for the families. They help to define the mortality risk of STXBP1 -related disorders and implement preventative strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Munc18 ProteinsSudden Unexpected Death in EpilepsyDrug Resistant EpilepsyHumansMaleFemaleAdolescentChildAdultInfantChild, PreschoolYoung AdultMiddle AgedCause of DeathRegistries

Stichwörter der Autor:innen

STXBP1Developmental and Epileptic Encephalopathy (DEE)Early mortalitySudden unexpected death in epilepsy (SUDEP)

Substanzen

Munc18 ProteinsSTXBP1 protein, human

Autor:innen und Institutionen

  • Department of Epilepsy Genetics and Personalized Treatment, Danish Epilepsy Center, Member of the European Reference Network EpiCARE, University of Southern Denmark, Dianalund, Denmark.
  • Institute for Regional Health Services, University of Southern Denmark, Odense, Denmark.
  • STXBP1 Foundation, Holly Springs, USA.
  • Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Victoria, Australia.
  • Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Florey Institute and Murdoch Children's Research Institute, Melbourne, VIC, Australia.
  • Department of Paediatrics, University of Galway, Galway, Ireland.

Förderung

  • STXBP1 Foundation
  • University of Southern Denmark

Zitieren

APA

Furia, F., Rigby, C. S., Scheffer, I. E., Allen, N., Baker, K., Hengsbach, C., Kegele, J., Goss, J., Gorman, K., Mala, M. I., Nicita, F., Allan, T., Spalice, A., Weber, Y., European STXBP1 consortium (ESCO), STXBP1 foundation, Rubboli, G., Møller, R. S., & Gardella, E. (2025). Early mortality in STXBP1-related disorders. Neurological Sciences. https://doi.org/10.1007/s10072-024-07783-3

Vancouver

Furia F, Rigby CS, Scheffer IE, Allen N, Baker K, Hengsbach C, et al. Early mortality in STXBP1-related disorders. Neurological Sciences. 2025. doi:10.1007/s10072-024-07783-3

BibTeX
@article{Furia2025,
  author = {Furia, Francesca and Rigby, Charlene Son and Scheffer, Ingrid E and Allen, Nicholas and Baker, Kate and Hengsbach, Christian and Kegele, Josua and Goss, James and Gorman, Kathleen and Mala, Misra-Isrie and Nicita, Francesco and Allan, Talia and Spalice, Alberto and Weber, Yvonne and European STXBP1 consortium (ESCO), European STXBP1 consortium (ESCO) and STXBP1 foundation, STXBP1 foundation and Rubboli, Guido and Møller, Rikke S and Gardella, Elena},
  title = {Early mortality in STXBP1-related disorders},
  journal = {Neurological Sciences},
  year = {2025},
  doi = {10.1007/s10072-024-07783-3}
}
Kostenlos starten →